comprehensive -WSS

comprehensive

author：comprehensive 2025-10-02 21:00:40 - browse：688

Alex Hogan/STAT

SAN FRANCISCO — It seemed like there was a point during last year’s J.P. Morgan Healthcare Conference when we all collectively realized, “Oh, 2023 is going to be another slog.” Indeed, a downturn has weighed on the biotech industry for nearly three years.

But this January, things feel different. Maybe it’s the abundance of sunlight that filled San Francisco this week. More likely, it’s the surge of deals that came in December. Whatever the reason, sentiment around Union Square in recent days was markedly more positive this year.

Most everyone I spoke to this week noticed the change in tenor. “I’m feeling a lot of good energy, honestly,” Mira Chaurushiya, senior partner at VC Westlake Village BioPartners, told me Tuesday. “It’s not only what happened the last few weeks of the year, but what people are projecting moving forward.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： ActiGraph execs on goal of drug approvals with digital endpoints

WSS

ActiGraph execs on goal of drug approvals with digital endpoints

At ASCO, pharma leaders speak of advances in 'smart bomb' drugs

Change Healthcare can notify patients about the breach, HHS says

ProMED sees offers of support, but its future remains unclear

For one rare type of lung cancer, Pfizer pill reduces progression by 81%

ASCO24: AstraZeneca won cancer’s big meeting. Can it fulfill its $80B ambition?

explore

comprehensive

explore

United colonoscopy coverage change 'may cost lives,' doctors say

Liz Cheney makes 1st public comment since Trump's election interference indictments

How one medical school became remarkably diverse

How to increase colonoscopy rates? Looks like an AI can help

State Dept. review finds Biden bears some blame for Afghanistan failures

Shifting the focus from loneliness to social health

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Baltimore teen accused of firing into crowd during block party mass shooting

Apple is now the first public company to be valued at $3 trillion

ActiGraph execs on goal of drug approvals with digital endpoints

Wikipedia

See how much Covid

ASCO: AstraZeneca says CAR

New definition of a human embryo proposed amid rapid advances

NIH documents show early flaws of $1.6 billion long Covid program

Hilary expected to bring catastrophic, life

Baltimore teen accused of firing into crowd during block party mass shooting

hotspot

focus

leisure time

explore